+Search query
-Structure paper
Title | Oxazolo[5,4-f]quinoxaline-type selective inhibitors of glycogen synthase kinase-3 alpha (GSK-3 alpha ): Development and impact on temozolomide treatment of glioblastoma cells. |
---|---|
Journal, issue, pages | Bioorg. Chem., Vol. 134, Page 106456-106456, Year 2023 |
Publish date | Aug 26, 2022 (structure data deposition date) |
Authors | Hasyeoui, M. / Lassagne, F. / Erb, W. / Nael, M. / Elokely, K.M. / Chaikuad, A. / Knapp, S. / Jorda, A. / Valles, S.L. / Quissac, E. ...Hasyeoui, M. / Lassagne, F. / Erb, W. / Nael, M. / Elokely, K.M. / Chaikuad, A. / Knapp, S. / Jorda, A. / Valles, S.L. / Quissac, E. / Verreault, M. / Robert, T. / Bach, S. / Samarat, A. / Mongin, F. |
External links | Bioorg. Chem. / PubMed:36913879 |
Methods | X-ray diffraction |
Resolution | 2.15 - 2.66 Å |
Structure data | PDB-8auz: PDB-8av1: |
Chemicals | ChemComp-SO4: ChemComp-O9C: ChemComp-HOH: ChemComp-EDO: ChemComp-O9L: |
Source |
|
Keywords | TRANSFERASE / kinase / GSK3B / inhibitor / Structural Genomics / Structural Genomics Consortium / SGC |